Liver transplantation is linked to durable survival for patients with neuroendocrine liver metastases, but careful patient ...

Zocilurtatug pelitecan has shown clinically meaningful responses and manageable safety in heavily pretreated patients with ...

First-line treatment duration may be a clinically useful predictor for 177Lu-DOTATATE retreatment patient selection, ...

According to data from the SwissNET registry of patients with GI-NETS, response to [177Lu]Lu-edotreotide is not influenced by ...

NETest2.0 accurately identified active NET disease and provided clinically meaningful longitudinal surveillance information.

Patients with NETS who have lower physical activity levels have greater fatigue and worse quality of life than those who are more physically active.

Nearly 20% of patients with M0 pancreatic neuroendocrine tumors (pNETS) go on to develop metastases within 4 years after ...

Cabozantinib improves PFS over placebo in patients with functional or nonfunctional extrapancreatic or pancreatic ...

Odds of radiotherapy nonadherence and three-year recurrence risk both lower, while disease-free survival improved ...

Gynecologic cancer highlights from ESMO 2026 include results from FONTANA, REJOICE-Ovarian02, and other studies with positive ...

The new ASTRO guideline is based on a systematic review of evidence and expert opinion and includes recommendations for MHF, ...

A sustained OS improvement is seen in patients with metastatic or recurrent cervical cancer who receive atezolizumab plus bevacizumab and chemo.